Pfizer Inc (PFE)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 88,203,000 | 92,286,000 | 87,700,000 | 92,282,000 | 89,014,000 | 96,934,000 | 99,019,000 | 100,971,000 | 95,661,000 | 92,631,000 | 87,209,000 | 82,424,000 | 77,201,000 | 75,691,000 | 70,042,000 | 68,620,000 | 63,238,000 | 65,259,000 | 64,336,000 | 65,026,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $88,203,000K
= 0.00
The debt-to-equity ratio for Pfizer Inc has consistently remained at 0.00 for all reported periods from March 31, 2020, to December 31, 2024. This indicates that Pfizer has not utilized debt financing for its operations but has relied solely on equity to fund its activities during this period. A debt-to-equity ratio of 0.00 implies that the company has no debt obligations relative to its equity, which may suggest a conservative capital structure or a strong financial position with minimal financial risk. It is essential to consider other factors alongside the debt-to-equity ratio when evaluating Pfizer's financial health and risk profile, such as profitability, liquidity, and overall business strategy.
Peer comparison
Dec 31, 2024